Human corticotropin-releasing factor plus lysine vasopressin test during glucocorticoid therapy.

1.0 micrograms/kg body wt human corticotropin-releasing factor (hCRF) and 0.005 IU/kg body wt lysine vasopressin (LVP) were administered in a bolus dose to patients receiving daily or alternate-day glucocorticoid therapy. In normal subjects with this hCRF-LVP test, the plasma ACTH increment was sign...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Clin Invest
Principais autores:	Hashimoto, K, Suemaru, S, Takao, T, Sugawara, M, Hattori, T, Kageyama, J, Takahashi, K, Ota, Z
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Clinical Investigation 1988
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC303469/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2839544/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI113561
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!